SEC Company Response from OSCIENT PHARMACEUTICALS CORP (CIK 0000356830) — Dec 29, 2005
OSCIENT PHARMACEUTICALS CORP (CIK 0000356830)
Date: Dec. 29, 2005 · CIK: 0000356830 · Accession: 0001193125-05-250448
AI Filing Summary & Sentiment
Referenced dates: December 22, 2005
Letter
Securities and Exchange Commission 100 First Street N.E. Washington, D.C 20549 Attn. Christine Allen, Division of Corporation Finance
Dear Ms. Allen,
We are in receipt of your letter dated December 22, 2005 regarding the SEC’s review of Oscient Pharmaceuticals Form 10-K for the year ended December 31, 2004. As we discussed, we hereby request a 30-day extension to respond to the comments until February 2, 2006 so we can prepare a detailed response and provide you the requested information.
If you have any questions, please contact me at 781-398-2604.
Sincerely,
/s/ Robert E. Farrell, Jr. CPA
Show Raw Text
CORRESP 1 filename1.htm SEC Letter December 29, 2005 Securities and Exchange Commission 100 First Street N.E. Washington, D.C 20549 Attn. Christine Allen, Division of Corporation Finance Dear Ms. Allen, We are in receipt of your letter dated December 22, 2005 regarding the SEC’s review of Oscient Pharmaceuticals Form 10-K for the year ended December 31, 2004. As we discussed, we hereby request a 30-day extension to respond to the comments until February 2, 2006 so we can prepare a detailed response and provide you the requested information. If you have any questions, please contact me at 781-398-2604. Sincerely, /s/ Robert E. Farrell, Jr. CPA Corporate Controller & Treasurer